Why the study?
To assess the safety and effectiveness of Hospital-at-Home by programme type (early-supported discharge vs admission avoidance) and determine which model provides stronger evidence for clinical, length of stay, and cost outcomes.
Does Hospital-at-Home (HaH) improve mortality, readmissions, costs, and length of stay compared to inpatient care?
Does Hospital-at-Home (HaH) improve mortality, readmissions, costs, and length of stay compared to inpatient care?
Hospital-at-Home models, particularly admission avoidance strategies, offer similar or improved clinical outcomes compared with traditional inpatient treatment.
No takes yet. Share an insight, caveat, or question.
May support admission avoidance Hospital-at-Home to ease inpatient demand; extends Level 1 evidence for comparable safety versus traditional care.
Leong et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: